MK-677 (Ibutamoren): GH Secretagogue Research | telos rx
Couple holds hands while walking down a path.
← Back to blog
growth hormone

MK-677 (Ibutamoren): Growth Hormone Secretagogue Overview

By TelosRX Editorial Team Updated

MK-677 (Ibutamoren) is an orally active growth hormone secretagogue studied in preclinical and clinical research. This page is an educational overview. telos rx does not offer or prescribe MK-677.

What Is MK-677?

MK-677 (Ibutamoren) is a non-peptide compound that mimics ghrelin signaling. It is studied in research for growth hormone axis activity.

MK-677 is not an FDA-approved drug.

Where MK-677 Shows Up in Research

MK-677 comes up most often in research on:

  • The growth hormone axis
  • Sleep quality
  • Body composition
  • Recovery

Clinical studies have also reported increased appetite, fluid retention and rises in blood glucose with ongoing use, which is one reason caution is warranted.

Regulatory Context

MK-677 is not FDA-approved. It was not among the peptides reviewed by the FDA's Pharmacy Compounding Advisory Committee in July 2026, and it is not covered by the interim enforcement discretion policy HHS announced on October 28, 2026, which applies only to BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500.

Does telos rx Offer MK-677?

No. telos rx does not offer, prescribe or ship MK-677.

Important Information

MK-677 is not FDA-approved. This article is for education only and is not medical advice.

Want to read more? Browse our Peptide Research blog.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX